Growth & profitability
- Revenue has grown 14.6% per year over the past 5 years.
- Operating margin has expanded, at -8.1% in the latest year.
CDNA Financials Caredx, Inc.
14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $380M | -$21M | 0.0% | -8.1% | — | — | $65M |
| 2024 | $334M | $53M | 0.0% | 12.2% | — | — | $115M |
| 2023 | $280M | -$190M | 0.0% | -72.5% | — | — | $82M |
| 2022 | $322M | -$77M | 0.0% | -24.0% | — | — | $90M |
| 2021 | $296M | -$31M | 0.0% | -10.0% | — | — | $348M |
| 2020 | $192M | -$19M | 0.0% | -11.7% | — | $0 | $135M |
| 2019 | $127M | -$22M | 64.2% | -19.3% | — | $0 | $38M |
| 2018 | $77M | -$47M | 56.9% | -20.3% | -$6M | $0 | $65M |
| 2017 | $48M | -$55M | 55.8% | -42.0% | -$14M | $34M | $17M |
| 2016 | $41M | -$39M | 0.0% | -91.9% | -$17M | $24M | $17M |
| 2015 | — | -$14M | — | — | — | $16M | $30M |
| 2014 | — | $781000 | — | — | — | $11M | $36M |
| 2013 | — | -$4M | — | — | — | $15M | $5M |
| 2012 | — | -$5M | — | — | — | — | $6M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $118M | $3M | 0.0% | 1.0% | $514000 | — | $78M |
| Dec '25 | $108M | -$4M | 0.0% | -5.6% | — | — | $65M |
| Sep '25 | $100M | $2M | 0.0% | -0.2% | — | — | $91M |
| Jun '25 | $87M | -$9M | 0.0% | -12.8% | — | — | $68M |
| Mar '25 | $85M | -$10M | 0.0% | -15.8% | -$28M | — | $89M |
| Dec '24 | $87M | $88M | 0.0% | 97.5% | — | — | $115M |
| Sep '24 | $83M | -$11M | 0.0% | -16.6% | — | $0 | $95M |
| Jun '24 | $92M | -$5M | 0.0% | -7.9% | — | $0 | $96M |
| Mar '24 | $72M | -$20M | 0.0% | -31.3% | — | — | $93M |
| Dec '23 | $66M | -$118M | 0.0% | -187.0% | — | — | $82M |
| Sep '23 | $67M | -$23M | 0.0% | -42.8% | — | — | $76M |
| Jun '23 | $70M | -$25M | 0.0% | -39.3% | — | — | $88M |
| Mar '23 | $77M | -$24M | 0.0% | -31.5% | — | — | $75M |
| Dec '22 | $82M | -$18M | 0.0% | -23.2% | — | — | $90M |
| Sep '22 | $79M | -$17M | 0.0% | -21.8% | — | — | $83M |
| Jun '22 | $81M | -$22M | 0.0% | -26.9% | — | — | $167M |
| Mar '22 | $79M | -$20M | 0.0% | -24.0% | — | — | $172M |
| Dec '21 | $79M | -$16M | 0.0% | -19.4% | — | — | $348M |
| Sep '21 | $76M | -$12M | 0.0% | -11.5% | -$3M | — | $353M |
| Jun '21 | $74M | -$2M | 0.0% | -6.4% | $7M | — | $336M |
Valuation over time
How the market has priced CDNA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has fallen from 21.0× (Dec '24) to 17.6× (Nov '25).
- The price-to-sales ratio has risen from 1.5× (Mar '23) to 3.8× (Jun '26).
P/E
P/S
Frequently asked questions
Is CDNA growing its revenue and profit?
Over the past 5 years, Caredx, Inc.'s revenue has grown 14.6% per year. These are computed facts, not advice.
How much debt does CDNA have?
As of FY2025, Caredx, Inc. reported — of total debt against $65M of cash.
What is CDNA's profit margin?
In FY2025, gross margin was —, operating margin -8.1%, and net margin -5.6%.
What is CDNA's P/E ratio?
As of Jun '26, Caredx, Inc. traded at a price-to-earnings ratio of about 17.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.